Penumbra Inc (PEN) stock
PENNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/3073% above fair value
$320.01−0.59 (-0.18%)
Close on Nov 19, 2026Market cap $12.61BP/E 80.6Yield –
Penumbra gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Penumbra's gross profit for the twelve months ending Sep 30, 2026 was $1.06B, up 19.1% year over year. For fiscal 2025 it was $942.44M, up 24.8% from the year before. Over ten years it grew 22.5% a year on average. The highest annual figure on record is $942.44M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $942.44M | +24.8% |
| FY2024 | Dec 31, 2024 | $755.00M | +10.6% |
| FY2023 | Dec 31, 2023 | $682.64M | +27.5% |
| FY2022 | Dec 31, 2022 | $535.21M | +12.6% |
| FY2021 | Dec 31, 2021 | $475.38M | +40.6% |
| FY2020 | Dec 31, 2020 | $338.18M | -9.1% |
| FY2019 | Dec 31, 2019 | $371.96M | +27.2% |
| FY2018 | Dec 31, 2018 | $292.53M | +34.7% |
| FY2017 | Dec 31, 2017 | $217.14M | +27.1% |
| FY2016 | Dec 31, 2016 | $170.83M | +37.7% |
| FY2015 | Dec 31, 2015 | $124.06M | +49.8% |
| FY2014 | Dec 31, 2014 | $82.84M | +43.1% |
| FY2013 | Dec 31, 2013 | $57.88M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $280.30M | +16.6% |
| Q2 FY2026 | Jun 30, 2026 | $264.94M | +18.3% |
| Q1 FY2026 | Mar 31, 2026 | $253.41M | +17.4% |
| Q4 FY2025 | Dec 31, 2025 | $262.13M | +24.4% |
| Q3 FY2025 | Sep 30, 2025 | $240.42M | +20.0% |
| Q2 FY2025 | Jun 30, 2025 | $224.01M | +37.6% |
| Q1 FY2025 | Mar 31, 2025 | $215.88M | +19.2% |
| Q4 FY2024 | Dec 31, 2024 | $210.72M | +12.7% |
| Q3 FY2024 | Sep 30, 2024 | $200.31M | +12.7% |
| Q2 FY2024 | Jun 30, 2024 | $162.83M | -2.4% |
| Q1 FY2024 | Mar 31, 2024 | $181.14M | +19.9% |
| Q4 FY2023 | Dec 31, 2023 | $186.99M | +35.1% |
| Q3 FY2023 | Sep 30, 2023 | $177.72M | +31.3% |
| Q2 FY2023 | Jun 30, 2023 | $166.86M | +24.5% |
| Q1 FY2023 | Mar 31, 2023 | $151.07M | +18.6% |
| Q4 FY2022 | Dec 31, 2022 | $138.43M | +10.3% |
| Q3 FY2022 | Sep 30, 2022 | $135.33M | +12.9% |
| Q2 FY2022 | Jun 30, 2022 | $134.04M | +12.9% |
| Q1 FY2022 | Mar 31, 2022 | $127.42M | +14.4% |
| Q4 FY2021 | Dec 31, 2021 | $125.45M | +33.0% |
| Q3 FY2021 | Sep 30, 2021 | $119.91M | +31.9% |
| Q2 FY2021 | Jun 30, 2021 | $118.69M | +82.8% |
| Q1 FY2021 | Mar 31, 2021 | $111.34M | +26.5% |
| Q4 FY2020 | Dec 31, 2020 | $94.31M | -3.9% |
| Q3 FY2020 | Sep 30, 2020 | $90.92M | -5.3% |
| Q2 FY2020 | Jun 30, 2020 | $64.93M | -30.9% |
| Q1 FY2020 | Mar 31, 2020 | $88.01M | +4.9% |
| Q4 FY2019 | Dec 31, 2019 | $98.13M | +24.7% |
| Q3 FY2019 | Sep 30, 2019 | $96.00M | +28.0% |
| Q2 FY2019 | Jun 30, 2019 | $93.93M | +30.0% |
| Q1 FY2019 | Mar 31, 2019 | $83.91M | +26.1% |
| Q4 FY2018 | Dec 31, 2018 | $78.71M | +23.5% |
| Q3 FY2018 | Sep 30, 2018 | $75.01M | +36.9% |
| Q2 FY2018 | Jun 30, 2018 | $72.25M | +41.9% |
| Q1 FY2018 | Mar 31, 2018 | $66.56M | +39.5% |
| Q4 FY2017 | Dec 31, 2017 | $63.73M | +36.8% |
| Q3 FY2017 | Sep 30, 2017 | $54.78M | – |
| Q2 FY2017 | Jun 30, 2017 | $50.93M | – |
| Q1 FY2017 | Mar 31, 2017 | $47.71M | – |
| Q4 FY2016 | Dec 31, 2016 | $46.58M | – |
See a number that looks wrong?